Apellis Pharmaceuticals Inc logo

Apellis Pharmaceuticals Inc

$ 61.04 -7.26 (-10.63%) 10:08 PM EST
P/E:
At Loss
P/B:
19.50
Market Cap:
$ 6.71B
Enterprise V:
$ 6.86B
Volume:
4.86M
Avg Vol (2M):
1.37M
Also Trade In:
Volume:
4.86M
Market Cap $:
6.71B
PE Ratio:
At Loss
Avg Vol (2-Month):
1.37M
Enterprise Value $:
6.86B
PB Ratio:
19.50
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3 the central protein in the complement cascade.
Name Current Vs Industry Vs History
Cash-To-Debt 4.04
Equity-to-Asset 0.33
Debt-to-Equity 0.63
Debt-to-EBITDA -0.35
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.09
Distress
Grey
Safe
Beneish M-Score 20.67
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 41.01
9-Day RSI 44.88
14-Day RSI 47.2
6-1 Month Momentum % 14.02
12-1 Month Momentum % 86.63

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.57
Quick Ratio 7.19
Cash Ratio 6.73
Days Inventory 1151.58
Days Sales Outstanding 21.3
Days Payable 623.05

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -20.1

Financials (Next Earnings Date:2022-11-08 Est.)

APLS's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:APLS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 96.643
EPS (TTM) ($) -6.69
Beta 1.8
Volatility % 54.08
14-Day RSI 47.2
14-Day ATR ($) 4.211297
20-Day SMA ($) 63.657
12-1 Month Momentum % 86.63
52-Week Range ($) 30.1707 - 70
Shares Outstanding (Mil) 109.87

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Apellis Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Apellis Pharmaceuticals Inc Analysis

Share your research

Headlines

See More
No news.